Streamlining Recruitment in a Phase 3 Pulmonary Study
Study Objectives Competitive enrollment of 5,000 participants across multiple sites, within a 48-month enrollment window. Alliance Clinical Network Goal: Enroll […]
Study Objectives Competitive enrollment of 5,000 participants across multiple sites, within a 48-month enrollment window. Alliance Clinical Network Goal: Enroll […]
Conducting clinical trials in Type 2 Diabetes (T2D) presents a unique set of challenges at the site level. Sites are
The following table provides a brief history of GLP-1 therapies that have received FDA regulatory approval. In addition to identifying brand name,
Study Objectives Enroll 4,000 participants across multiple global sites. Alliance Clinical Network Goal: Enroll 300 participants (150 per site) within
Achieving diversity in clinical trials is critical to ensuring safe, effective therapies and equitable health outcomes, as well as fostering
As the vaccine industry advances, recruiting participants for clinical trials becomes more complex. Clinical development professionals face challenges such as
High screen failure rates in central nervous system (CNS), neurological, and psychiatric clinical trials are among the most significant barriers
Background The U.S. Food and Drug Administration (FDA) is actively seeking diversity in clinical trials. While Caucasians represent 58% of
Southlake, Texas, October 8, 2024 Alliance Clinical Network announced that Angie Noel will join as its Chief Human Resources Officer.
Southlake, Texas, October 1, 2024: Today, Alliance Clinical Network announced that Pete Beardsley will join the company as Chief Commercial